Literature DB >> 10891989

Gait disturbances in patients with pontine medial tegmental lesions: clinical characteristics and gait analysis.

H Mitoma1, R Hayashi, N Yanagisawa, H Tsukagoshi.   

Abstract

OBJECTIVE: To determine the clinical characteristics of gait disorders in patients with pontine medial tegmental lesions.
DESIGN: We compared features of gait disorders between patients with infarcts in the medial tegmentum and those with stroke in other areas of the pons (pathological control subjects) by measuring electromyographic results of lower limb muscles and several biomechanical parameters. PATIENTS: Two patients with infarcts in the rostral medial tegmentum and 4 control subjects. Two of the control patients had lesions in the pontine base, while the lesions in the other 2 were in the pontine tegmentum and base (combined lesions).
RESULTS: Patients with rostral medial tegmental lesions and controls with pontine base lesions showed unstable walking characterized by irregular angular displacements and foot pressures. However, they differed by the following 3 features. (1) Rostral medial tegmental lesions elicited truncal ataxia without limb ataxia. In comparison, pontine base lesions elicited limb ataxia without truncal ataxia and caused hemiparesis. (2) Instability was more severe and persistent in patients with the former lesions than in those with the latter lesions. Slowness of walking speed and prolongation of the double-support period were clearly observed in the former group. (3) Electromyographic changes characteristic of cerebellar ataxia were clearly evident in patients with rostral medial tegmental lesions. The electromyographic amplitudes of the gastrocnemius and tibialis anterior muscles were almost constant throughout the gait cycle, resulting in the disappearance of the inherent periodic pattern of each muscle.
CONCLUSION: Medial tegmental lesions in the rostral pons cause prolonged and severe unstable walking that resembles spinocerebellar ataxic pattern, and impairment of the spinocerebellar loop might be the pathomechanism underlying such a gait disturbance.

Entities:  

Mesh:

Year:  2000        PMID: 10891989     DOI: 10.1001/archneur.57.7.1048

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

Review 1.  Higher level gait disorders.

Authors:  Philip D Thompson
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

2.  Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings.

Authors:  Heike Jacobi; Till-Karsten Hauser; Paola Giunti; Christoph Globas; Peter Bauer; Tanja Schmitz-Hübsch; László Baliko; Alessandro Filla; Caterina Mariotti; Maria Rakowicz; Perine Charles; Pascale Ribai; Sandra Szymanski; Jon Infante; Bart P C van de Warrenburg; Alexandra Dürr; Dagmar Timmann; Sylvia Boesch; Roberto Fancellu; Rafal Rola; Chantal Depondt; Ludger Schöls; Elzbieta Zdzienicka; Jun-Suk Kang; Susanne Ratzka; Berry Kremer; Dennis A Stephenson; Béla Melegh; Massimo Pandolfo; Sophie Tezenas du Montcel; Johannes Borkert; Jörg B Schulz; Thomas Klockgether
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

3.  Quantitative assessment of brain stem and cerebellar atrophy in spinocerebellar ataxia types 3 and 6: impact on clinical status.

Authors:  L Eichler; B Bellenberg; H K Hahn; O Köster; L Schöls; C Lukas
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-03       Impact factor: 3.825

4.  Successful removal of an impacted metallic arrowhead penetrating up to the brainstem.

Authors:  Dharmdas Paramhans; Sapna Shukla; Ankur Batra; Raj K Mathur
Journal:  J Emerg Trauma Shock       Date:  2010-07

Review 5.  A review of heat shock protein induction following cerebellar injury.

Authors:  Laura P R Reynolds; Gary V Allen
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

6.  Internuclear ophthalmoplegia plus ataxia indicates a dorsomedial tegmental lesion at the pontomesencephalic junction.

Authors:  Sun-Uk Lee; Hyo-Jung Kim; Jeong-Jin Park; Ji-Soo Kim
Journal:  J Neurol       Date:  2016-03-19       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.